Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF

AS McLean; SJ Huang; B Tang; M Nalos

首页> 外文期刊>Critical care : >Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF

【24h】

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF

机译：左西孟旦通过血浆B型利钠肽（BNP）和LVEF评估对失代偿性心力衰竭的重症患者有益

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Critical care :》 |2003年第2期|共页
作者
AS McLean; SJ Huang; B Tang; M Nalos;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure. [J] . Farmakis D, Parissis JT, Bistola International Journal of Cardiology . 2010,第1期

机译：血浆B型利钠肽减少预测急性失代偿性慢性心力衰竭对左西孟旦治疗的长期反应。
2. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. [J] . Cohen Solal A, Logeart D, Huang B Journal of the American College of Cardiology . 2009,第25期

机译：严重急性失代偿性心力衰竭患者对左西孟旦或多巴酚丁胺治疗的反应中B型利钠钠肽水平降低与存活率提高相关。
3. Response to Letters to the Editor: Short-term effects of levosimendan and prostaglandin E1 on haemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure [J] . Deddo Moertl European Journal of Heart Failure . 2006,第2期

机译：致编辑的信的回复：左西孟旦和前列腺素E1对失代偿性慢性心力衰竭患者血液动力学参数和B型利钠肽水平的短期影响
4. B-Type Natriuretic Peptide (BNP) Detection Using Electrochemical Immunosensor Based On Sandwich ELISA With Horseradish Peroxidase-Tetramethylbenzidine System [C] . Yeni Wahyuni Hartati, Ratna Nurmalasari, Shabarni Gaffar World Congress on Biosensors . 2016

机译：B型利钠肽（BNP）使用基于夹心酶的电化学免疫传感器与辣根过氧化物酶 - 四甲基苯胺系统使用电化学免疫传感器检测
5. A Combination Assay with B-type Natriuretic Peptide (BNP) and High Sensitive Troponin I (hsTnI) for the Detection of Potential Cardiovascular Diseases [D] . 須川聡 2019

机译：B型利钠肽（BNP）和高敏感性肌钙蛋白I（hsTnI）的组合检测方法，用于检测潜在的心血管疾病
6. Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF [O] . AS McLean, SJ Huang, B Tang, 2003

机译：左西孟旦对通过血浆B型利钠肽（BNP）和LVEF评估的失代偿性心力衰竭重症患者受益
7. Heart failure assessed based on plasma B-type natriuretic peptide (BNP) levels negatively impacts activity of daily living in patients with hip fracture [O] . Yusuke Tamamura, Micihko Matsuura, Sumiko Shiba, 2020

机译：基于血浆B型利钠肽（BNP）水平评估的心力衰竭对髋部骨折患者的日常生活活动产生负面影响

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF

著录项

相似文献

相关主题

期刊订阅